Loss of the deubiquitinase OTULIN promotes hepatocellular carcinoma (HCC) in an mTOR-dependent manner

Cell Death Differ. 2020 May;27(5):1455-1456. doi: 10.1038/s41418-020-0531-2. Epub 2020 Mar 30.

Antonio Marzio^{1

2}, Michele Pagano^{3

4

5}

¹ Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA.
² Perlmutter Cancer Center, New York University School of Medicine, New York, NY, 10016, USA.
³ Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA. michele.pagano@nyulangone.org.
⁴ Perlmutter Cancer Center, New York University School of Medicine, New York, NY, 10016, USA. michele.pagano@nyulangone.org.
⁵ Howard Hughes Medical Institute, New York University School of Medicine, New York, NY, 10016, USA. michele.pagano@nyulangone.org.

No abstract available

Publication types